The association of psychedelic use and opioid use disorders among illicit users in the United States

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial

(2016) Yih-Ing Hser et al.   ADDICTION

Detection of “bath salts” and other novel psychoactive substances in hair samples of ecstasy/MDMA/“Molly” users

(2016) Joseph J. Palamar et al.   DRUG AND ALCOHOL DEPENDENCE

Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)

(2016) Matthew M. Nour et al.   Frontiers in Human Neuroscience

The role of serotonin in drug use and addiction

(2015) Christian P. Müller et al.   BEHAVIOURAL BRAIN RESEARCH

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

(2015) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

(2015) Michael P Bogenschutz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Trends in Opioid Analgesic Abuse and Mortality in the United States

(2015) Richard C. Dart et al.   NEW ENGLAND JOURNAL OF MEDICINE

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects

(2014) Peter Gasser et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

(2014) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010

(2014) Marcus A. Bachhuber et al.   JAMA Internal Medicine

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

(2012) Peter Oehen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabinoid–Opioid Interaction in Chronic Pain

(2011) D I Abrams et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Longitudinal relationships of religious worship attendance and spirituality with major depression, anxiety disorders, and suicidal ideation and attempts: Findings from the Baltimore epidemiologic catchment area study

(2011) Daniel Rasic et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Effects of Direct- and Indirect-Acting Serotonin Receptor Agonists on the Antinociceptive and Discriminative Stimulus Effects of Morphine in Rhesus Monkeys

(2011) Jun-Xu Li et al.   NEUROPSYCHOPHARMACOLOGY

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Expanded Biology of Serotonin

(2009) Miles Berger et al.   Annual Review of Medicine

Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys

(2008) Sean Esteban McCabe et al.   ADDICTIVE BEHAVIORS

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder

(2007) Vibe G. Frokjaer et al.   BIOLOGICAL PSYCHIATRY